The origins of estrogen receptor alpha-positive and estrogen receptor alpha-negative human breast cancer.
about
Tamoxifen may prevent both ER+ and ER- breast cancers and select for ER- carcinogenesis: an alternative hypothesis.Potential therapeutic implications of IL-6/IL-6R/gp130-targeting agents in breast cancerBreast cancer risk accumulation starts early: prevention must alsoMammary gland stem cells and their application in breast cancerMicroRNA cluster 221-222 and estrogen receptor alpha interactions in breast cancerThe role of cadmium and nickel in estrogen receptor signaling and breast cancer: metalloestrogens or not?Understanding the premalignant potential of atypical hyperplasia through its natural history: a longitudinal cohort study.A gene transcription signature associated with hormone independence in a subset of both breast and prostate cancersA mouse model for luminal epithelial like ER positive subtype of human breast cancer.Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics.Spontaneous feline mammary intraepithelial lesions as a model for human estrogen receptor- and progesterone receptor-negative breast lesionsGenetically engineered ERα-positive breast cancer mouse models.Nuclear-encoded mitochondrial MTO1 and MRPL41 are regulated in an opposite epigenetic mode based on estrogen receptor status in breast cancer.In vivo and in vitro studies suggest a possible involvement of HPV infection in the early stage of breast carcinogenesis via APOBEC3B induction.Tip30 controls differentiation of murine mammary luminal progenitor to estrogen receptor-positive luminal cell through regulating FoxA1 expressionMammary development and breast cancer: the role of stem cellsChallenging the roles of CD44 and lipolysis stimulated lipoprotein receptor in conveying Clostridium perfringens iota toxin cytotoxicity in breast cancer.Role of ERalpha in the differential response of Stat5a loss in susceptibility to mammary preneoplasia and DMBA-induced carcinogenesisSomatic expression of PyMT or activated ErbB2 induces estrogen-independent mammary tumorigenesis.Histone deacetylase inhibitors equipped with estrogen receptor modulation activity.Estrogen-induced apoptosis of breast epithelial cells is blocked by NO/cGMP and mediated by extranuclear estrogen receptors.Targeting proapoptotic protein BAD inhibits survival and self-renewal of cancer stem cellsSelected antioxidants and risk of hormone receptor-defined invasive breast cancers among postmenopausal women in the Women's Health Initiative Observational Study.Estrogen mediated-activation of miR-191/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor status.Fool's gold, lost treasures, and the randomized clinical trial.Quantitative assessment of the association between rs2046210 at 6q25.1 and breast cancer riskTip30 deletion in MMTV-Neu mice leads to enhanced EGFR signaling and development of estrogen receptor-positive and progesterone receptor-negative mammary tumors.Assessing interactions between the association of common genetic variant at 1p11 (rs11249433) and hormone receptor status with breast cancer riskThe role of miR-206 in the epidermal growth factor (EGF) induced repression of estrogen receptor-alpha (ERalpha) signaling and a luminal phenotype in MCF-7 breast cancer cells.Reproductive factors and risk of hormone receptor positive and negative breast cancer: a cohort studyThe role of lipolysis stimulated lipoprotein receptor in breast cancer and directing breast cancer cell behavior.Simultaneous Inhibition of Estrogen Receptor and the HER2 Pathway in Breast Cancer: Effects of HER2 AbundanceResistance to everolimus driven by epigenetic regulation of MYC in ER+ breast cancers.Economic evaluation of hormonal therapies for postmenopausal women with estrogen receptor-positive early breast cancer in CanadaP53 genotype as a determinant of ER expression and tamoxifen response in the MMTV-Wnt-1 model of mammary carcinogenesisMetabolism and its sequelae in cancer evolution and therapy.Mouse models of estrogen receptor-positive breast cancerEarly Breast Cancer Precursor Lesions: Lessons Learned from Molecular and Clinical StudiesA transformation in the mechanism by which the urokinase receptor signals provides a selection advantage for estrogen receptor-expressing breast cancer cells in the absence of estrogenExpression of functional toll like receptor 4 in estrogen receptor/progesterone receptor-negative breast cancer.
P2860
Q25257858-FB08AF76-4FD8-4172-9A91-E36950A157D3Q26769917-D1DF7346-354A-45B3-B07C-FB335D8EF6E5Q26851902-53447704-7896-4D96-9E6A-A9BB9D85EB87Q28075791-D1B08C75-F732-4591-958D-00B3C48922D7Q28114800-C85F40EC-BEBE-457B-9EAB-C7B843A9B44BQ28390036-377D2A36-36CE-43BB-BE28-309206C5C230Q30408300-8A03E78B-15B1-458D-A8AF-74222368A2C0Q33289245-0360DCF2-769F-483C-9775-8D4DB6921038Q33299625-6DDE3FA3-887E-4ADE-8AC0-E898A8DB537EQ33330850-28D24DD2-7E7C-4CB3-80EB-17F5916B5FBBQ33562282-4AB5A4EB-28C5-47A7-A711-BE105A8B04E4Q33578641-38DBAAF3-20B5-4027-8001-CA059FBDA6F0Q33588369-46225B7D-A3A6-45D8-A842-B5544A48A5BFQ33654853-114E60E4-F941-4007-B1D9-C52548DB275DQ33720151-3956DF0B-61AA-4EC5-A4F3-4CEFB377A7CEQ33735595-56092D44-5E6A-474C-AC10-49675A8AC49AQ33864348-E4A1C169-D94B-4EC6-A61A-4B37F0C238CBQ33884587-D32A8713-16A6-4899-ACB1-482D810317E1Q34105355-B1F25096-4818-43C0-B1C9-DC19841E22E8Q34352264-82ECE3D4-D0F6-4E83-ADBC-77E54F759CCEQ34392623-C16A90D9-64DB-46FC-AEA8-0D0275369FDBQ34486457-EB544966-B97E-4C13-94B4-455CC5EF1A5DQ34590323-545E5ABC-4F6E-445A-BA71-A5F473795F85Q34625392-C03D5E6A-C067-4879-86ED-9E779579F8DDQ34669260-8454B4CB-7414-427E-BD04-09A4CA39B1E2Q34778648-9F65E978-64A9-4684-8C6F-B549D997D7AEQ34783850-CDAC40A0-ACB5-4430-9AD4-619FE6D1ECCDQ34973879-995A1759-B950-457D-A6B2-77F3DC6F432EQ34979726-70AE5A66-589B-4AF7-AC8A-D0BA23D697E9Q35062955-12879660-2848-423C-AE55-E1E364A2B975Q35122705-02B90123-26E4-448E-976D-75C18D2FC954Q35182591-2008839B-B75E-4520-9EAB-1026B336A545Q35273689-5CA42953-B08E-4BA1-9DA7-283C76AB20A8Q35445037-D795AC0C-7417-4A4F-8476-95C6C16BC4C4Q35455993-CA740CA7-69F8-4A6E-A4BF-306450CCD962Q35657799-10842419-8CD7-441A-A92A-CBAC3AB4DD58Q35685892-6D373867-6AEA-449E-9F76-BB16B2094675Q35940073-3C4779C4-1454-43EE-A8E2-583260C4B9F7Q36059078-3887E31A-AD4C-403B-9FFB-2BE83E06E090Q36082731-76E7D1FB-E713-40BD-90C1-22DCCBB16250
P2860
The origins of estrogen receptor alpha-positive and estrogen receptor alpha-negative human breast cancer.
description
2004 nî lūn-bûn
@nan
2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
The origins of estrogen recept ...... a-negative human breast cancer
@nl
The origins of estrogen recept ...... -negative human breast cancer.
@ast
The origins of estrogen recept ...... -negative human breast cancer.
@en
type
label
The origins of estrogen recept ...... a-negative human breast cancer
@nl
The origins of estrogen recept ...... -negative human breast cancer.
@ast
The origins of estrogen recept ...... -negative human breast cancer.
@en
prefLabel
The origins of estrogen recept ...... a-negative human breast cancer
@nl
The origins of estrogen recept ...... -negative human breast cancer.
@ast
The origins of estrogen recept ...... -negative human breast cancer.
@en
P2093
P2860
P921
P3181
P356
P1476
The origins of estrogen recept ...... -negative human breast cancer.
@en
P2093
D Craig Allred
Daniel Medina
Powel Brown
P2860
P2888
P304
P3181
P356
10.1186/BCR938
P407
P577
2004-09-22T00:00:00Z
P5875
P6179
1020688988